Search results for "Sclerosing"

showing 10 items of 69 documents

Endoscopic sclerotherapy for hemostasis of acute esophageal variceal bleeding.

2014

Introduction. Currently the most widely used methods for endoscopic control of esophageal varices bleeding are sclerotherapy and rubber band ligation. Although the superiority of band ligation (BL) over endoscopic sclerotherapy (SCL) for the secondary prophylaxis of variceal hemorrhage has been proven, the best approach for acute bleeding remains controversial. Patients and methods. We performed a retrospective study between January 2005 and May 2013. We selected 104 patients with gastrointestinal hemorrhage from rupture of esophageal varices treated with endoscopic sclerotherapy. The sclerosing agent used was 1% polidocanol in 89 cases, butyl-cyanoacrylate in 8 cases and sodium tetradecyls…

AdultMalePolidocanolReproducibility of ResultsEnbucrilateMiddle Agedendoscopic sclerotherapyEsophageal and Gastric VaricesSclerosing SolutionsPolyethylene GlycolsSodium Tetradecyl SulfateTreatment OutcomeRecurrenceSclerotherapyHumansFemaleOriginal ArticleEsophagoscopyGastrointestinal Hemorrhageesophageal variceal bleedingLigationAgedRetrospective Studies
researchProduct

Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany - Limitations of th…

2010

Summary Since the introduction of model for end-stage liver disease (MELD) in 2006, post-orthotopic liver transplantation (OLT) survival in Germany has declined. The aim of this study was to evaluate risk factors and prognostic scores for outcome. All adult OLT recipients in seven German transplant centers after MELD implementation (December 2006–December 2007) were included. Recipient data were analyzed for their influence on 1-year outcome. A total of 462 patients (mean calculated MELD = 20.5, follow-up: 1 year) were transplanted for alcoholic cirrhosis (33.1%), hepatocellular carcinoma (26.6%), Hepatitis-C (17.1%), Hepatitis-B (9.5%), primary sclerosing cholangitis (5.6%) and late graft-…

AdultMaleReoperationmedicine.medical_specialtyAlcoholic liver diseaseCarcinoma HepatocellularTissue and Organ ProcurementAdolescentmedicine.medical_treatmentMedizinLiver transplantationSeverity of Illness IndexGastroenterologyPrimary sclerosing cholangitisEnd Stage Liver DiseaseLiver diseaseModel for End-Stage Liver DiseaseRisk FactorsGermanyInternal medicinemedicineHumansRisk factorIntensive care medicineAgedRetrospective StudiesHepatitisTransplantationHealth Care Rationingbusiness.industryLiver NeoplasmsOdds ratioMiddle Agedmedicine.diseaseSurvival AnalysisLiver Transplantationbody regionsTreatment OutcomeFemalebusiness
researchProduct

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients with Inflammatory Bowel Disease.

2013

International audience; BACKGROUND AND AIMS:: There is an unclear risk of colonic high-grade dysplasia (HGD) and colorectal cancer (CRC) among patients with inflammatory bowel disease (IBD) treated with immunosuppressants. We analyzed data on CRC development among patients with IBD enrolled in the observational cohort Cancers et Surrisque Associé aux Maladies Inflammatoires Intestinales En France (CESAME). METHODS:: We followed and collected data from 19,486 patients with IBD (60.3% with Crohn's disease, 30.1% receiving thiopurine therapy) enrolled in CESAME from May 2004 and June 2005, and followed until December 2007. When the study began, 2841 patients (14.6%) were characterized as havin…

AdultMaleRiskmedicine.medical_specialtyColorectal cancerPopulationInflammatory bowel diseaseGastroenterologyPrimary sclerosing cholangitisCohort Studies03 medical and health sciences0302 clinical medicine[ CHIM.ORGA ] Chemical Sciences/Organic chemistryInternal medicinemedicineHumansProspective StudiesProspective cohort studyeducationAged 80 and overeducation.field_of_studyCrohn's diseaseHepatologyThiopurine methyltransferasebiology[CHIM.ORGA]Chemical Sciences/Organic chemistrybusiness.industryIncidenceGastroenterologyMiddle AgedInflammatory Bowel Diseasesmedicine.diseaseUlcerative colitisdigestive system diseases3. Good health030220 oncology & carcinogenesisMultivariate Analysisbiology.proteinFemale030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessPrecancerous Conditions
researchProduct

A simple method to treat post-kydney transplantation lymphocele

2011

OBJECTIVE: To describe our experience with ultrasonic-guided instillation of povidone-iodine to treat post-kidney transplantation lymphocele. Patients and methods. We studied the safety and efficacy of this procedure for treatment of lymphocele in 6 male kidney transplanted recipients in which we assisted a progressive increase of creatinine and urinary proteins levels and color-Doppler ultrasonography demonstrated an increase (25,4%) of index of resistence (IR) Using eco-colorDoppler, the related-graft lymphocele location and the distance to the anterior abdominal wall were determined; then, a radiopaque double-lumen catheter was used to instillate 5% povidone-iodine 10 ml. Results. Percut…

AdultMaleSettore MED/18 - Chirurgia GeneraleInstillation DrugLymphoceleSclerotherapyHumansMiddle AgedUS-guided percutaneous treatmentKidney TransplantationPovidone-IodineSclerosing SolutionsUltrasonography
researchProduct

Benign oral vascular lesions treated by sclerotherapy with ethanolamine oleate : a retrospective study of 43 patients

2017

Background Although sclerotherapy is a common treatment for benign oral vascular lesions, there is no well-standardized protocol for this purpose. The aim of the present study was to describe the clinical characteristics of patients treated by sclerotherapy with ethanolamine oleate (EO), in order to contribute to a better understanding of this technique. Material and Methods Medical records and images of 90 patients treated by the same sclerotherapy protocol were retrieved and analysed. Thus, 43 cases with complete information were selected and described. Results The most affected age group was 41–70 years, with a female predominance and 86% of patients being Caucasian. Lips were the most a…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentOleic AcidsGastroenterologyCongenital AbnormalitiesLesion03 medical and health sciencesYoung Adult0302 clinical medicineTongueInternal medicineSclerotherapymedicineSclerotherapyHumansYoung adultEthanolamine OleateChildGeneral DentistryAgedRetrospective StudiesMouthOral Medicine and Pathologybusiness.industryMedical recordResearchClinical appearanceRetrospective cohort study030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Sclerosing Solutionsmedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASBlood VesselsSurgeryFemaleMouth Neoplasmsmedicine.symptombusinessHemangioma
researchProduct

Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the E…

2021

Knowledge of living donor liver transplantation (LDLT) for autoimmune liver diseases (AILDs) is scarce. This study analyzed survival in LDLT recipients registered in the European Liver Transplant Registry with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis (PSC) and the non-autoimmune disorder alcohol-related cirrhosis. In total, 29 902 individuals enrolled between 1998 and 2017 were analyzed, including 1003 with LDLT. Survival from >90 days after LDLT for AILDs in adults was 85.5%, 74.2%, and 58.0% after 5, 10, and 15 years. Adjusted for recipient age, sex, and liver transplantation era, adult PSC patients receiving LDLT showed increased mortality compare…

AdultMalemedicine.medical_specialtyBrain DeathCirrhosisMultivariate analysis[SDV]Life Sciences [q-bio]Medizinliving donorDiseaseAutoimmune hepatitisinflammatory030230 surgeryclinical research/practiceGastroenterologyPrimary sclerosing cholangitis03 medical and health sciences0302 clinical medicinepatient survivalInternal medicinemedicinePrimary Sclerosing CholangitisLiving DonorsImmunology and AllergyRisk-FactorsHumansPharmacology (medical)RegistriesChildRetrospective StudiesTransplantationbusiness.industryLiver DiseasesHazard ratioGraft SurvivalCohort[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterologymedicine.disease3. Good healthDonation after brain deathLiver TransplantationTreatment Outcome030211 gastroenterology & hepatologyimmuneMorbidityLiving donor liver transplantationbusinessliver diseaseliver transplantation/hepatologyAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsREFERENCES
researchProduct

Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and foll…

2006

Background and study aims We present ten patients who developed secondary sclerosing cholangitis following long-term treatment in an intensive care unit (ICU) between 1999 and 2004. Patients and methods Ten consecutive patients who had no evidence suggestive of pre-existing hepatobiliary disease were admitted to an ICU because of trauma (n = 5), intracerebral hemorrhage (n = 3), or nonabdominal postsurgical complications (n = 2). All the patients had required treatment with long-term ventilation, catecholamines, total parenteral nutrition, and several antimicrobial agents. Results Cholestasis was first noted within 11 days after the initial insult. Endoscopic retrograde cholangiopancreatogr…

AdultMalemedicine.medical_specialtyCholangitis SclerosingIntrahepatic bile ductslaw.inventionLiver diseaseCholestasislawMedicineHumansAgedIntracerebral hemorrhageCholangiopancreatography Endoscopic RetrogradeEndoscopic retrograde cholangiopancreatographyCholestasismedicine.diagnostic_testbusiness.industryHepatobiliary diseaseGastroenterologyLength of StayMiddle Agedmedicine.diseaseIntensive care unitSurgeryIntensive Care UnitsSecondary sclerosing cholangitisFemalebusinessEndoscopy
researchProduct

Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis.

2008

In post-infancy, multinucleated giant cell hepatitis is rare. Various conditions and diseases associated with post-infantile giant cell hepatitis have been described, but the pathogenesis remains unknown. In this paper we review the case reports of four patients (3 male, 1 female; aged 22 to 32 years) with primary sclerosing cholangitis and autoimmune hepatitis. The follow-up ranges from five to seven years. All patients showed cholestasis and repeated elevation of hepatic transaminases. Patients with viral infections, metabolic disorders and toxic influences were excluded. Histopathology of liver tissue in all four patients revealed giant cell formation with up to 20 nuclei in 20-70% of al…

AdultMalemedicine.medical_specialtyPathologyCirrhosisCholangitisAutoimmunityAutoimmune hepatitisGiant CellsPrimary sclerosing cholangitisHepatitisCholestasisAdrenal Cortex HormonesHLA AntigensmedicineHumansAspartate AminotransferasesAutoimmune diseaseHepatitisCholangiopancreatography Endoscopic RetrogradeCholestasisHepatologybusiness.industryHistocytochemistryUrsodeoxycholic AcidAlanine TransaminaseBilirubinmedicine.diseaseSerologyGiant cellHistopathologyFemalebusinessImmunosuppressive AgentsLiver
researchProduct

Bacteremia after proctoscopy and hemorrhoidal injection sclerotherapy

1981

The incidence of bacteremia following proctoscopy and hemorrhoidal injection sclerotherapy was studied in 50 outpatients undergoing both procedures. Bacteremia was found in 2 per cent of the subjects after proctoscopy and in 8 per cent after sclerotherapy. None of the subjects developed symptoms of septicemia following the procedure. It is concluded that antibiotic prophylaxis should be used before sclerotherapy in patients with valvular heart disease or compromised host defense.

AdultMalemedicine.medical_specialtyPremedicationmedicine.medical_treatmentHemorrhoidsProctoscopySepsisHemorrhoidsSepsismedicineSclerotherapyHumansAgedmedicine.diagnostic_testbusiness.industryvalvular heart diseaseGastroenterologyGeneral MedicineMiddle Agedbacterial infections and mycosesmedicine.diseaseSclerosing SolutionsColorectal surgeryAnti-Bacterial AgentsProctoscopySurgeryBacteremiaAnesthesiaFemalePremedicationbusinessDiseases of the Colon & Rectum
researchProduct

Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients

2021

Background. The influence of sex on primary sclerosing cholangitis (PSC), pre- and postliver transplantation (LT) is unclear. Aims are to assess whether there have been changes in incidence, profile, and outcome in LT-PSC patients in Europe with specific emphasis on sex. Methods. Analysis of the European Liver Transplant Registry database (PSC patients registered before 2018), including baseline demographics, donor, biochemical, and clinical data at LT, immunosuppression, and outcome. Results. European Liver Transplant Registry analysis (n = 6463, 32% female individuals) demonstrated an increasing number by cohort (1980-1989, n = 159; 1990-1999, n = 1282; 2000-2009, n = 2316; 2010-2017, n =…

AdultMalemedicine.medical_specialtyTime FactorsDatabases Factualmedicine.medical_treatmentCholangitis SclerosingPopulation030230 surgeryLiver transplantationRisk AssessmentPrimary sclerosing cholangitis03 medical and health sciencesSex Factors0302 clinical medicineRisk FactorsInternal medicinemedicineHumansRegistriesHealthcare DisparitieseducationTransplantationeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Graft SurvivalImmunosuppressionHealth Status DisparitiesMiddle Agedmedicine.diseaseLiver TransplantationEuropeTransplantationTreatment OutcomeMale patientCohortFemale030211 gastroenterology & hepatologybusinessTransplantation
researchProduct